Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Jun 11;16:162. doi: 10.1186/s12967-018-1537-0

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2018

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 5 — Cell viability assay results for doxorubicin treatment and miR-197 transfection in diffuse large B-cell lymphoma cell lines. Upon treatment with a series of doxorubicin concentrations in diffuse large B-cell lymphoma cells of non-germinal center/activated B cell-like (non-GCB/ABC; SUDHL9) phenotype and GCB origin (OCI-LY1), cell viability was significantly reduced in the miR-197 transfection group compared with that in the scrambled control group. SUDHL9, an ABC DLBCL cell line, exhibited significant miR-197-transfection-induced reduction in cell viability at lower concentrations of doxorubicin (a) compared with OCI-Ly1, a GCB DLBCL cell line (b)